id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-E-1978-0008,FDA,FDA-2019-E-1978,Notice of Final Determination from U.S. Patent and Trademark Office to Cooley LLP,Other,Letter(s),2024-02-27T05:00:00Z,2024,2,2024-02-27T05:00:00Z,,2024-02-27T15:31:27Z,,0,0,09000064863d6270
FDA-2019-E-1978-0011,FDA,FDA-2019-E-1978,Letter from U. S. Patent Trademark Office to FDA CDER,Other,Letter(s),2024-02-27T05:00:00Z,2024,2,2024-02-27T05:00:00Z,,2024-02-27T15:32:33Z,,0,0,090000648639038a
FDA-2019-E-1978-0009,FDA,FDA-2019-E-1978,Letter from U. S. Patent Trademark Office to Cooley LLP,Other,Letter(s),2024-02-27T05:00:00Z,2024,2,2024-02-27T05:00:00Z,,2024-02-27T15:31:41Z,,0,0,09000064863d626e
FDA-2019-E-1978-0010,FDA,FDA-2019-E-1978,Requirement for Information from U.S Patent and Trademark Office to Cooley LLP,Other,Letter(s),2024-02-27T05:00:00Z,2024,2,2024-02-27T05:00:00Z,,2024-02-27T15:31:55Z,,0,0,09000064863d6272
FDA-2019-E-1978-0007,FDA,FDA-2019-E-1978,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2023-11-15T05:00:00Z,2023,11,2023-11-15T05:00:00Z,,2023-11-15T18:56:04Z,,0,0,090000648627e385
FDA-2019-E-1978-0006,FDA,FDA-2019-E-1978,Determination of Regulatory Review Period for Purposes of Patent Extension; DOPTELET,Notice,Determinations,2023-02-06T05:00:00Z,2023,2,2023-02-06T05:00:00Z,2023-04-08T03:59:59Z,2024-02-05T14:00:04Z,2023-02482,0,0,0900006485633e6e
FDA-2019-E-1978-0005,FDA,FDA-2019-E-1978,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2023-02-02T05:00:00Z,2023,2,2023-02-02T05:00:00Z,,2023-02-02T15:39:19Z,,0,0,090000648562ca75
FDA-2019-E-1978-0004,FDA,FDA-2019-E-1978,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2022-12-29T05:00:00Z,2022,12,2022-12-29T05:00:00Z,,2022-12-29T21:18:14Z,,0,0,090000648555fe31
FDA-2019-E-1978-0003,FDA,FDA-2019-E-1978,Letter from FDA to U.S. Patent and Trademark Office,Other,Letter(s),2019-06-21T04:00:00Z,2019,6,2019-06-21T04:00:00Z,,2019-06-21T13:52:27Z,,0,0,0900006483d30599
FDA-2019-E-1978-0002,FDA,FDA-2019-E-1978,"Patent Extension Application from Cooley LLP (on behalf of Astellas Pharma, Inc.)",Other,Application,2019-04-24T04:00:00Z,2019,4,2019-04-24T04:00:00Z,,2019-04-24T15:27:28Z,,0,0,0900006483beb43f
FDA-2019-E-1978-0001,FDA,FDA-2019-E-1978,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2019-04-24T04:00:00Z,2019,4,2019-04-24T04:00:00Z,,2019-04-24T15:24:00Z,,0,0,0900006483beb680